Candel Therapeutics (NASDAQ:CADL) reported its Q4 earnings results on Thursday, March 28, 2024 at 08:05 AM. Here’s what investors need to know about the announcement. EarningsCandel Therapeutics missed estimated earnings by -138.0%, reporting an EPS of $-0.38 versus an estimate of $-0.16. Revenue was down $31 thousand from the same period last year. Past Earnings PerformanceLast quarter the company missed on EPS by $0.1 which was followed by a 4.0% increase in the share price the next day. ** Listen to the earnings announcement yourself by clicking here. ** To track all earnings releases for C…